UNH revenue grew 11.8% to $447.6B in 2025, but net income fell 16.3% to $12.06B, reflecting margin pressure. The stock trades at a 20.6% PE premium to peers and sits above its 200-day moving average, suggesting the market is pricing in a recovery. Hold until there is evidence that the earnings decline is transitory and that AI-driven efficiency gains can restore profitability.
Medicare Advantage overpayment scrutiny
Congressional committee findings of $7B in annual overpayments could lead to rate cuts, directly hitting a key revenue segment.
Medical cost inflation
The steep drop in operating income from $32.3B to $19.0B year-over-year may signal persistent medical loss ratio headwinds.
AI integration fails to offset core headwinds
Optum's AI-driven turnaround may not scale quickly enough to counter margin compression in UnitedHealthcare.
Elevated debt and declining free cash flow
Total debt rose to $78.4B while FCF fell to $16.1B, reducing flexibility for buybacks or bolt-on M&A.